MLVA Genotyping Characteristics of Human Brucella melitensis Isolated from Ulanqab of Inner Mongolia, China

Brucellosis is a serious public health problem in Ulanqab, which is a region located in the middle of the Inner Mongolia Autonomous Region adjacent to Shanxi and Hebei provinces. The disease is prevalent in both the latter provinces and Ulanqab with the highest prevalence of brucellosis occurring in Inner Mongolia. The MLVA-16 scheme is a genotyping tool for assessing genetic diversity and relationships among isolates. Moreover, this genotyping tool can also be applied to epidemiological trace-back investigations. This study reports the occurrence of at least two B. melitensis biovars (1 and 3) in Ulanqab, encompassing 22 and 94 isolates, respectively. B. melitensis biovar 3 was the predominant biovar in the area examined. Panel 1 (MLVA-8) identified three genotypes (42, 63, and 114), with genotype 42 (n = 101) representing 87% of the tested strains. MLVA-11 identified eight genotypes (116, 111, 297, 291, and 342–345) from 116 of the analyzed isolates. All of these isolates were identified as belonging to the East Mediterranean group. Genotype 116 (n = 94) was the predominant genotype and represented 81% of the isolates. The isolates pertaining to this genotype were distributed throughout most of Ulanqab and neighboring regions. The MLVA-16 scheme showed the presence of 69 genotypes, with 46 genotypes being represented by single isolates. This analysis revealed that Ulanqab brucellosis cases had epidemiologically unrelated and sporadic characteristics. The remaining 23 genotypes were shared (between a total of 70 isolates) with each genotype being represented by two to eight isolates. These data indicate that these cases were epidemiologically related. MLVA genotyping confirmed the occurrence of a multipoint outbreak epidemic and intrafamilial brucellosis. Extensive genotype-sharing events were observed among isolates from different regions of Ulanqab and from other provinces of China. These findings suggest either a lack of control of animal movement between different regions or the circulation of contaminated animal products in the market. Our study is the first comprehensive genotyping and genetic analysis of B. melitensis in Ulanqab. We believe that this study will help to improve the effectiveness of brucellosis control programs.

[1]  Alexandre P. Francisco,et al.  PHYLOViZ 2.0: providing scalable data integration and visualization for multiple phylogenetic inference methods , 2017, Bioinform..

[2]  Georgios Pappas,et al.  The new global map of human brucellosis. , 2006, The Lancet. Infectious diseases.

[3]  G. Araj,et al.  Human brucellosis: a classical infectious disease with persistent diagnostic challenges. , 1999, Clinical laboratory science : journal of the American Society for Medical Technology.

[4]  B. Cui,et al.  Genotyping of Human Brucella melitensis Biovar 3 Isolated from Shanxi Province in China by MLVA16 and HOOF , 2015, PloS one.

[5]  G. Vergnaud,et al.  Evaluation of Brucella MLVA typing for human brucellosis. , 2007, Journal of microbiological methods.

[6]  P. Hunter,et al.  Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity , 1988, Journal of clinical microbiology.

[7]  Yin Jiming,et al.  Epidemiology and control of brucellosis in China. , 2002, Veterinary microbiology.

[8]  R. Gilman,et al.  Molecular Epidemiology of Brucella Genotypes in Patients at a Major Hospital in Central Peru , 2009, Journal of Clinical Microbiology.

[9]  M. Filipenko,et al.  Genetic diversity of Brucella abortus and Brucella melitensis in Kazakhstan using MLVA-16. , 2015, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[10]  J. Meis,et al.  In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014 – 2015 , 2015, BMC Microbiology.

[11]  B. Cui,et al.  MLVA and MLST typing of Brucella from Qinghai, China , 2016, Infectious Diseases of Poverty.

[12]  M. Corbel.  Recent advances in brucellosis. , 1997, Journal of medical microbiology.

[13]  F. Denoeud,et al.  Evaluation and selection of tandem repeat loci for a Brucella MLVA typing assay , 2006, BMC Microbiology.

[14]  G. Vergnaud,et al.  Molecular characterisation of Brucella species. , 2013, Revue scientifique et technique.

[15]  A. Whatmore,et al.  Identification and Characterization of Variable-Number Tandem-Repeat Markers for Typing of Brucella spp.† , 2022 .

[16]  A. Johansson,et al.  Multiple-Locus Variable-Number Tandem Repeat Analysis for Typing of Staphylococcus epidermidis , 2006, Journal of Clinical Microbiology.

[17]  B. Cui,et al.  MLVA Genotyping of Brucella melitensis and Brucella abortus Isolates from Different Animal Species and Humans and Identification of Brucella suis Vaccine Strain S2 from Cattle in China , 2013, PloS one.

[18]  A. Whatmore,et al.  Characterisation of the genetic diversity of Brucella by multilocus sequencing , 2007, BMC Microbiology.

[19]  G. Vergnaud,et al.  Multiple-Locus Variable-Number Tandem-Repeat Analysis Genotyping of Human Brucella Isolates from Turkey , 2011, Journal of Clinical Microbiology.

[20]  P. Calistri,et al.  Investigating genetic diversity of Brucella abortus and Brucella melitensis in Italy with MLVA-16. , 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[21]  S. Welburn,et al.  Narrative overview of animal and human brucellosis in Morocco: intensification of livestock production as a driver for emergence? , 2015, Infectious Diseases of Poverty.

[22]  E. Schelling,et al.  Molecular Epidemiology and Antibiotic Susceptibility of Livestock Brucella melitensis Isolates from Naryn Oblast, Kyrgyzstan , 2013, PLoS neglected tropical diseases.

[23]  B. Bricker,et al.  Differentiation of Brucella abortus bv. 1, 2, and 4, Brucella melitensis, Brucella ovis, and Brucella suis bv. 1 by PCR , 1994, Journal of clinical microbiology.

[24]  Alexandre P. Francisco,et al.  PHYLOViZ: phylogenetic inference and data visualization for sequence based typing methods , 2012, BMC Bioinformatics.

[25]  R. Skuce,et al.  Molecular Epidemiology of Brucella abortus in Northern Ireland—1991 to 2012 , 2015, PloS one.

[26]  S. Al Dahouk,et al.  Laboratory-based diagnosis of brucellosis--a review of the literature. Part II: serological tests for brucellosis. , 2003, Clinical laboratory.

[27]  S. Levidiotou,et al.  An eternal microbe: Brucella DNA load persists for years after clinical cure. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  Xiaoling Deng,et al.  MLVA genotyping of Chinese human Brucella melitensis biovar 1, 2 and 3 isolates , 2011, BMC Microbiology.

[29]  Hai Jiang,et al.  Genotyping of Brucella melitensis and Brucella abortus strains currently circulating in Xinjiang, China. , 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[30]  Z. Memish,et al.  Brucella bacteraemia: clinical and laboratory observations in 160 patients. , 2000, The Journal of infection.

[31]  J. Cruickshank.  The duration of bacteraemia in relation to the virulence of Brucella strains , 1957, Journal of Hygiene.

[32]  B. Garin‐Bastuji,et al.  MLVA16 Typing of Portuguese Human and Animal Brucella melitensis and Brucella abortus Isolates , 2012, PloS one.

[33]  S. Ebrahimpour,et al.  Human brucellosis: An overview , 2015, Caspian journal of internal medicine.

[34]  G. G. Alton,et al.  Laboratory techniques in brucellosis. , 1975, Monograph series. World Health Organization.

[35]  Gilles Vergnaud,et al.  Evaluation of a Multilocus Variable-Number Tandem-Repeat Analysis Scheme for Typing Human Brucella Isolates in a Region of Brucellosis Endemicity , 2008, Journal of Clinical Microbiology.

[36]  P. Le Flèche,et al.  Assessment of genetic stability of Brucella melitensis Rev 1 vaccine strain by multiple-locus variable-number tandem repeat analysis. , 2007, Vaccine.